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LETTERS

is of paramount importance and might provide valued insights into host–microbe interactions.
Our report confirms a novel Borrelia IGS sequence
type detected in situ from 2 relapsing fever patients. This
species showed greatest homology with the relapsing fever borreliae from Africa, B. recurrentis and B. duttonii,
but not with B. microti, which is transmitted by O. erraticus ticks, previously believed to be the only soft tick species in this region. These findings challenge the assumption that TBRF in Iran is attributed to only B. persica or
B. microti.
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To the Editor: I read with interest the report by Wei
et al. (1) regarding 2 cases of neonatal legionellosis associated with infant formula prepared with hospital tap water.
Two hospitals were involved, and water samples from both
were positive for Legionella pneumophila bacteria that had
molecular profiles indistinguishable from those for bacteria from the infected neonates. As Wei et al. (1) and others
have established, control of waterborne pathogens, such as
Legionella spp., in health care institutions remains a work
in progress.
Recently, leading medical centers have recognized the
efficacy and cost-effectiveness of performing certain measures to ensure the safety of hospital water. These measures
include routine microbial analyses of tap water and use
of waterborne pathogen prevention and control measures
such as hot water flushing of plumbing; use of chlorination,
chlorine dioxide, monochloramine, copper–silver ionization, or ultraviolet light; ozonation; and point-of-use water
filtration. Each method has advantages and disadvantages
related to ease of implementation, cost, maintenance issues, and short- and long-term effectiveness. Randomized
controlled trials comparing the efficacy of these strategies
are lacking, but the availability of guidance for using waterborne pathogen prevention and control strategies has
resulted in substantial declines in health care–associated
legionellosis (2). Efforts at waterborne pathogen detection
and control are complicated by the role of biofilm, comprising microbes embedded in the polymeric matrix attached
to internal plumbing surfaces, which protects waterborne
pathogens from adverse environmental conditions, including antimicrobial agents and systemic controls (e.g., ultraviolet light, metals, acid pH) (2,3).
Prevention of legionnellosis in health care settings
offers a clinically beneficial and cost-effective alternative to intermittent case detection and outbreak control.
For example, it has been demonstrated that, even in the
absence of a recognized outbreak, hospital units caring
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for immunosuppressed patients can reduce infection rates
by using water filtration at the point of use (4). Although
further efforts are needed to systematically evaluate Legionella spp. control measures, a progressive approach to
prevent health care–associated legionellosis includes routine microbial analysis of tap water in units for patients
at high risk for infection, use of systemic water disinfection technology, and use of point-of-use water filtration in
units where care is rendered for patients most vulnerable
to infection with Legionella spp.
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To the Editor: Carnobacterium spp. are ubiquitous
lactic acid bacteria isolated from cold and temperate environments (1). They are present in food including fish, meat,
and dairy products. Only C. divergens and C. maltaromaticum (formerly C. piscicola) are found in dairy products
(2). Carnobacteria are well known for their ability to produce bacteriocins that inhibit Listeria monocytogenes (1).
1
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Because Carnobacterium and Listeria bacteria are psychrotrophic and share the same ecologic niche, many studies have highlighted the potential use of carnobacteria as
a biopreservative (1). These bacteria were previously believed to be nonpathogenic for humans. We report a case of
C. divergens bacteremia in a woman.
In January 2013, a 57-year-old woman with a history
of diabetes mellitus, severe undernutrition, and chronic alcoholism was admitted to the intensive care unit of the Avicenne Hospital, Bobigny, France, for diabetic ketoacidosis
with altered level of consciousness. Physical examination
revealed a low body temperature (30.1°C) and epigastric
tenderness. At admission, a computed tomographic scan of
the abdomen showed pneumoperitoneum with low-abundance ascites. Antimicrobial therapy with piperacillin/tazobactam and amikacin was empirically started. Exploratory
laparotomy findings were within normal limits.
Three days after admission, acute necrotizing esophagitis (“black esophagus”) with multiple gastroduodenal ulcerations was diagnosed by gastrointestinal endoscopy. By then,
septic shock had developed. Antimicrobial drug therapy was
empirically changed to imipenem/cilastatin and amikacin. A
total esophagectomy with gastrostomy and esophagostomy
was performed. No etiology for black esophagus could be
established. Parenteral nutrition was begun 24 hours after
surgery and relieved with enteral nutrition 72 hours after surgery. On hospitalization day 13, after having clinically improved, the patient consecutively experienced 2 episodes of
hypoxemic cardiac arrest and resuscitation. Fever began 2.5
hours later and septic shock again developed. Exploratory
laparotomy findings ruled out ischemic colitis.
Four sets of blood cultures collected on 3 days over a
period of 5 days showed bacterial growth after 2 days of incubation in the BACTEC 9240 System (Becton Dickinson,
Franklin Lakes, NJ, USA). Gram-positive Listeria-like rods
were seen. Within 24 hours, the isolate grew on trypticase
soy agar with 5% horse blood and chocolate PolyViteX
agar (bioMérieux, Marcy l’Étoile, France). The colonies
were gray, 1–2 mm in diameter, and nonhemolytic. The
strain was facultative anaerobic. The catalase reaction was
negative, and the esculin hydrolysis reaction was quickly
positive. Results of testing with the API Coryne and API
Listeria systems (bioMérieux) were unclear. The isolate
seemed to be susceptible to penicillins, carbapenems, macrolides, and gentamicin and resistant to cephalosporins.
MICs were as follows: penicillin 0.19 mg/L, amoxicillin
0.125 mg/L, amoxicillin/clavulanic acid 0.094 mg/L, cefotaxime >32 mg/L, ofloxacin 1 mg/L, ciprofloxacin 0.38
mg/L, imipenem 0.064 mg/L, vancomycin 2 mg/L, teicoplanin 1 mg/L, linezolid 0.50 mg/L, amikacin 16 mg/L, and
rifampin 0.006 mg/L.
Because blood cultures were positive for gram-positive rods susceptible to amoxicillin, our initial diagnosis
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